A select group of breast cancer patients have been able to receive radiation directed to their tumor. What is the process that has been in use since 2002?

Prepare for the Cancer Management Test with multiple-choice questions, detailed explanations, and flashcard reviews. Get exam ready with us!

Multiple Choice

A select group of breast cancer patients have been able to receive radiation directed to their tumor. What is the process that has been in use since 2002?

Explanation:
Targeted radiation to the tumor bed using a brachytherapy device was developed to treat only the area at risk after lumpectomy. MammoSite uses a balloon catheter placed in the lumpectomy cavity, with a remote afterloader delivering a high-dose-rate Ir-192 source directly to the surrounding tissue. This approach, introduced and widely used starting around 2002, enables accelerated partial breast irradiation, shortening the overall treatment course compared with whole-breast radiation. While IMRT and IGRT are external-beam techniques that shape and verify dose across the breast, MammoSite embodies a localized, catheter-based method focused on the tumor bed.

Targeted radiation to the tumor bed using a brachytherapy device was developed to treat only the area at risk after lumpectomy. MammoSite uses a balloon catheter placed in the lumpectomy cavity, with a remote afterloader delivering a high-dose-rate Ir-192 source directly to the surrounding tissue. This approach, introduced and widely used starting around 2002, enables accelerated partial breast irradiation, shortening the overall treatment course compared with whole-breast radiation. While IMRT and IGRT are external-beam techniques that shape and verify dose across the breast, MammoSite embodies a localized, catheter-based method focused on the tumor bed.

More practice questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy